CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- 4 Other acquisition Executive Vice President & CFO acquired 74 shares (code L)
- 4 Other acquisition SVP, Clinical Solutions acquired 27 shares (code L)
- 4 Other acquisition SVP for Diagnostic Services acquired 81 shares (code L)
- 4 Grant or award Director acquired 68 shares (grant or award)
- 4 Other acquisition SVP & Chief Commercial Officer acquired 25 shares (code L)
- 4 Planned sale CEO and President sold 39,191 shares at an average $168.46 ($6,602,074)
- 4 Planned sale SVP, Clinical Solutions sold 2,555 shares at $170.00 ($434,350)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes SVP for Diagnostic Services gave up 162 shares (to pay taxes)
- 4 Shares withheld for taxes SVP & Chief Commercial Officer gave up 256 shares (to pay taxes)
- 4 Planned sale SVP & General Counsel sold 4,643 shares at $170.00 ($789,310)
- 4 Planned sale EVP, Regional Businesses sold 5,370 shares at $174.13 ($935,078)
- 4 Shares withheld for taxes SVP, Corp. Controller & CAO gave up 2,559 shares (to pay taxes)
- 4 Planned sale EVP, Regional Businesses sold 716 shares at $175.79 ($125,866)
- 4 Grant or award CEO and President acquired 61,917 shares (grant or award)
- 4 Grant or award SVP, Clinical Solutions acquired 4,434 shares (grant or award)
- 4 Grant or award SVP for Diagnostic Services acquired 5,674 shares (grant or award)
- 4 Planned sale SVP & General Counsel sold 592 shares at $175.79 ($104,068)
- 4 Grant or award SVP & Chief Commercial Officer acquired 5,317 shares (grant or award)
Page 7 of 74 · 1,466 filings